● Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Condition: Narcolepsy Type 2 · Sponsor: Alkermes, Inc.

PhasePhase 3

Planned participants176

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

The purpose of this study is to measure decreases in daytime sleepiness, and disease symptoms in participants with Narcolepsy Type 2 (NT2) when taking ALKS 2680 tablets compared with placebo tablets.

This description comes directly from the study's public registry record.

Talk to the study team

Director Clinical Trial Manager · 888-235-8008 (US Only) · clinicaltrials@alkermes.com

Director Clinical Trial Manager · 571-599-2702 (Global) · clinicaltrials@alkermes.com

Always discuss trial participation with your own doctor first.

Locations (19)

Alkermes Investigational Site	Cullman, Alabama, United States	Recruiting
Alkermes Investigational Site	Los Angeles, California, United States	Recruiting
Alkermes Investigational Site	Boulder, Colorado, United States	Recruiting
Alkermes Investigational Site	Brandon, Florida, United States	Recruiting
Alkermes Investigational Site	Maimi, Florida, United States	Recruiting
Alkermes Investigational Site	Winter Park, Florida, United States	Recruiting
Alkermes Investigational Site	Macon, Georgia, United States	Recruiting
Alkermes Investigational Site	Kansas City, Kansas, United States	Recruiting
Alkermes Investigational Site	Newton, Massachusetts, United States	Recruiting
Alkermes Investigational Site	Lansing, Michigan, United States	Not Yet Recruiting
Alkermes Investigational Site	Huntersville, North Carolina, United States	Recruiting
Alkermes Investigational Site	Cincinnati, Ohio, United States	Recruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07502443